Robert E. Hoffman serves as Executive at Kintara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert E. Hoffman has executed 3 insider transactions totaling $25.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 1, 2023 involved receiving (via award) 59,800 shares valued at $0.
Robert E. Hoffman currently holds 68,902 shares of Kintara Therapeutics, Inc. (KTRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Hoffman has been a net buyer of KTRA stock. They have purchased $25.9K and sold $0 worth of shares.
Robert E. Hoffman's most recent insider trade was on Jun 1, 2023, when they sold 59,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 15, 2022 | KTRA | $25.9K | Purchase | 55,000 | $0.47 | Discretionary |